Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare M Williams

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Health Science Reports|July 12, 2021
Detrimental impact of allergic airway disease on live attenuated influenza vaccineSreeja Roy, Clare M Williams, Yoichi Furuya
Bio-Protocol|March 4, 2021
A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial InfectionSean Roberts, Clare M Williams, Sreeja Roy, et al.
Vaccines|November 19, 2020
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) ImmunogenicitySreeja Roy, Clare M Williams, Danushka K Wijesundara, et al.
Nature|February 25, 2005
Counter-rotating microplates at the Galapagos triple junctionEmily M Klein, Deborah K Smith, Clare M Williams, et al.
Vaccines|August 23, 2020
Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective ImmunitySreeja Roy, Clare M Williams, Julian Pardo, et al.
Clinical & Translational Immunology|March 31, 2022
LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenzaClare M Williams, Sreeja Roy, Wei Sun, et al.
Mbio|July 4, 2019
Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae CoinfectionSean Roberts, Sharon L Salmon, Donald J Steiner, et al.
Vaccines|October 17, 2019
Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A InfectionSean Roberts, Clare M Williams, Sharon L Salmon, et al.
Journal of Virology|September 1, 2021
The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza VaccineClare M Williams, Sreeja Roy, Danielle Califano, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Health Science Reports|July 12, 2021
Detrimental impact of allergic airway disease on live attenuated influenza vaccineSreeja Roy, Clare M Williams, Yoichi Furuya
Bio-Protocol|March 4, 2021
A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial InfectionSean Roberts, Clare M Williams, Sreeja Roy, et al.
Vaccines|November 19, 2020
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) ImmunogenicitySreeja Roy, Clare M Williams, Danushka K Wijesundara, et al.
Nature|February 25, 2005
Counter-rotating microplates at the Galapagos triple junctionEmily M Klein, Deborah K Smith, Clare M Williams, et al.
Vaccines|August 23, 2020
Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective ImmunitySreeja Roy, Clare M Williams, Julian Pardo, et al.
Clinical & Translational Immunology|March 31, 2022
LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenzaClare M Williams, Sreeja Roy, Wei Sun, et al.
Mbio|July 4, 2019
Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae CoinfectionSean Roberts, Sharon L Salmon, Donald J Steiner, et al.
Vaccines|October 17, 2019
Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A InfectionSean Roberts, Clare M Williams, Sharon L Salmon, et al.
Journal of Virology|September 1, 2021
The Interleukin-33-Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza VaccineClare M Williams, Sreeja Roy, Danielle Califano, et al.
Pageof 1